CREYON Trademark

Trademark Overview

On Friday, July 23, 2021, a trademark application was filed for CREYON with the United States Patent and Trademark Office. The USPTO has given the CREYON trademark a serial number of 90979814. The federal status of this trademark filing is REGISTERED as of Tuesday, July 11, 2023. This trademark is owned by Creyon Bio, Inc.. The CREYON trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing health information in the field of precision medicine; providing a website featuring educational information regarding genetically based diseases, rare diseases, gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine, and other treatment options
creyon

General Information

Serial Number90979814
Word MarkCREYON
Filing DateFriday, July 23, 2021
Status700 - REGISTERED
Status DateTuesday, July 11, 2023
Registration Number7108800
Registration DateTuesday, July 11, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements

Goods and ServicesProviding health information in the field of precision medicine; providing a website featuring educational information regarding genetically based diseases, rare diseases, gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine, and other treatment options

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 23, 2021
Primary Code044
First Use Anywhere DateTuesday, March 8, 2022
First Use In Commerce DateTuesday, March 8, 2022

Trademark Owner History

Party NameCreyon Bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameCreyon Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameCreyon Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 11, 2023REGISTERED-PRINCIPAL REGISTER
Friday, June 9, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, June 8, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 17, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 17, 2023USE AMENDMENT FILED
Wednesday, May 17, 2023DIVISIONAL PROCESSING COMPLETE
Monday, May 15, 2023DIVISIONAL REQUEST RECEIVED
Monday, May 15, 2023TEAS REQUEST TO DIVIDE RECEIVED
Monday, May 15, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, April 25, 2023ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Monday, April 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 3, 2023TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 12, 2022NON-FINAL ACTION E-MAILED
Thursday, May 12, 2022NON-FINAL ACTION WRITTEN
Monday, April 18, 2022ASSIGNED TO EXAMINER
Thursday, September 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 27, 2021NEW APPLICATION ENTERED

Related Keywords

creyon medicine providing precision therapy diseases information cell regenerative other options